CONFLICTS OF INTEREST
Parkinson’s, Zambon
FOX
FS is an Editorial Board member of this journal, but was not involved in the peer-review process nor had access to any information regarding its peer review and has received grants and/or research support from Zambon and honoraria or consultation fees from Bial, Biogen, Britania Pharmaceuticals, Chiesi, Cynapsus Therapeutics, Kyowa Kirin, Lundbeck, NeuroDerm, Sunovion Pharmaceuticals Inc., and Zambon.OR has received grants and/or research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, Michael J. Fox Foundation, and Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020) and honoraria or consultation fees from AbbVie, Adamas, Acorda, Aguettant, Alkahest, AlzProtect, ApoPharma, AstraZeneca, Bial, Biogen, Britannia Pharmaceuticals, Bukwang, Cerevel, Clevexel, Irlab, Eli-Lilly, Lundbeck, NeuroDerm, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Pfizer, Prexton Therapeutics, Sanofi, Servier, Sunovion Pharmaceuticals Inc., Theranexus, Takeda, Teva Pharmaceuticals, UCB, Watermark Research, XenoPort, XO, and Zambon.WP has received grants and/or research support from Michael J. Fox Foundation, EU FP7 & Horizon 2020; personal fees from AC Immune, Alterity, AbbVie, Affiris, Bial, Biogen, Britannia Pharmaceuticals, Eli Lilly, Lundbeck, NeuroDerm, Neurocrine, Roche, Sunovion Pharmaceuticals Inc., Stada, Takeda, UCB, and Zambon; and royalties from Cambridge University Press, Oxford University Press, Thieme, and Wiley Blackwell.KRC is an Editorial Board member of this journal, but was not involved in the peer-review process nor had access to any information regarding its peer review and has received grants and/or research support from BIAL, EU Horizon 2020, Parkinson’s UK, NIHR, Parkinson’s Foundation, and Wellcome Trust and honoraria or consulting fees from 4D Pharma, AbbVie, Acadia, Bial, Boehringer Ingelheim, Britannia Pharmaceuticals, Cynapsus Therapeutics, GKC, Kyowa Kirin, Lobsor Pharmaceuticals, Novartis, Profile Pharma, Roche, Scion, SK Pharma, Stada, Sunovion Pharmaceuticals Inc., Theravance Biopharma, UCB Pharma, and Zambon.JK has received honoraria or consultation fees from AbbVie, Bial, Biogen, Desitin, Esteve, Licher MT, Medtronic, NeuroDerm, Novartis, STADA, UCB Pharma, and Zambon; in addition, he is Specialty Chief Editor in LLM has received compensated advisory services, consulting, research grant support, or speaker honoraria from AbbVie, Bial, Italfarmaco, NeuroDerm, Roche, Stada, Sunovion Pharmaceuticals Inc., UCB Pharma, and Zambon.YZ, AB, and EP were employees of Sunovion Pharmaceuticals Inc. at the time the analyses were conducted.SW is an employee of Sumitomo Pharma America, Inc.